DataMEDS AI, Inc. (MEDS)
MEDSNASDAQ-CMOther Pharmaceuticals
$0.9065
-0.0780 (-7.92%) today
At the close, Nov 10, 4:00 PM ET. After hours $0.9065 +1.14%
- Market cap
- $4.32m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $0.8500 to $1.04
- 52-week range
- $0.8225 to $35.50
- Average volume
- 8.08m
- Previous close
- $0.9845
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $3.01m | $1.67m | $1.56m | $1.78m |
| Gross profit | $231.0k | -$7.86m | $170.0k | $182.0k |
| Operating income | -$31.55m | -$25.35m | -$6.02m | -$7.34m |
| Net income | -$34.32m | -$27.85m | -$7.74m | -$18.36m |
Last four quarters: revenue $8.02m, margin -1100.2%, free cash flow –
News
8 latest- DataMeds' Helomics Secures Humana Medicaid Coverage For ChemoFx Cancer Assay; Stock Up RTTNews · Oct 12, 2026
- DataMeds AI Climbs Over 25% On Launch Of GLP-1-Focused Health Lives Here App RTTNews · Sep 28, 2026
- Weekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead RTTNews · Sep 18, 2026
- DataMeds AI Settlement Eliminates $19 Million In Liabilities; Retires 364,099 Shares; Stock Up RTTNews · Sep 18, 2026
- Biotech Stocks See Fresh Catalysts: Tempest, DataMEDS, NeurAxis & MAIA RTTNews · Sep 16, 2026
- DataMEDS AI Buys Helomics Cancer Lab And CRO Assets As Shares Jump 170% In Pre-Market RTTNews · Sep 16, 2026
- Pre Market Movers: WGRX, CODX, AIM Set The Pace RTTNews · May 28, 2026
- Wellgistics Health Announces 1-for-50 Reverse Stock Split To Regain Nasdaq Compliance; Stock Plunges RTTNews · May 21, 2026
The company
DataMEDS AI, Inc. (NASDAQ:MEDS), formerly Wellgistics Health, Inc. , is a healthcare company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units through its health information technology platforms to deliver a better experience for consumers and providers. Headquartered in Tampa, Fla. , DataMEDS incorporates its EinsteinRx artificial intelligence platform and PharmacyChain blockchain-enabled smart contracts platform into the Health Lives Here mobile application from Tollo Health, LLC , and its pharmacy-related Corexa Health subsidiary provides pharmacy dispensing and pharmacy-related services, including distribution of products developed by Tollo Health . DataMEDS also owns Helomics Corporation , a Pittsburgh, PA -based commercial clinical molecular diagnostics laboratory focused on the ChemoFx Assay chemotherapy selection diagnostics test that aims to help oncologists make chemotherapy treatment decisions.
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- wellgisticshealth.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.